-
Why Cassava Sciences Stock Is Trading Higher Today
Tuesday, December 21, 2021 - 12:03pm | 281Read More...Cassava Sciences Inc (NASDAQ: SAVA) is trading higher Tuesday after the company was informed by Neuroscience journal that there was no evidence to support data manipulation claims in a 2005 company-authored paper. In August, a law firm representing admitted short sellers submitted a...
-
Pain Therapeutics Gains 7%, FDA Has Accepted Company's Remoxy For Review
Wednesday, April 13, 2016 - 11:32am | 179Read More...Shares of Pain Therapeutics, Inc. (NASDAQ: PTIE), a micro-cap biopharmaceutical company whose lead drug candidate, REMOXY, is used for the treatment of moderate to severe pain. Pain Therapeutics announced after Tuesday's market close the U.S. Food and Drug Administration determined that its...
